For instance, the glucose transporter type 1 (GLUT1) inhibitor WZB117 blocks glucose entry into cancer cells, disrupting glycolysis, reducing intracellular ATP and glycolytic enzymes, ultimately causing cell cycle arrest, senescence, and necrosis (3, 34). The gene discussed is HK1; the disease is cancer.